| Univariate Analysis |
Multivariate Analysis | ||
|---|---|---|---|
| P | HR (95% CI) | P | |
| Age | 0.081 | 1.032 (1.011 – 1.053) | 0.003 |
| Gender | 0.190 | ||
| Tumor location | 0.984 | ||
| Adenoma-like adenocarcinoma | 0.035 | ||
| Tumor budding | <0.001 | ||
| Intraepithelial tumor infiltrating lymphocytes | 0.002 | 0.010 | |
| Yes | 1 | ||
| No | 2.332 (1.221 – 4.453) | ||
| Lymphovascular invasion | <0.001 | ||
| Perineural invasion | 0.006 | ||
| Tumor deposits | <0.001 | ||
| Stromal reaction | <0.001 | <0.001 | |
| Immature/myxoid | 3.085 (1.629 – 5.843) | ||
| Intermediate | 0.932 (0.466 – 1.864) | ||
| Mature | 1 | ||
| MMR expression | 0.744 | ||
| pT-stage | <0.001 | ||
| pN-stage | <0.001 | ||
| pTNM prognostic stage group | <0.001 | <0.001 | |
| I | 0.118 (0.035 – 0.394) | ||
| II | 0.349 (0.196 – 0.622) | ||
| III | 1 | ||
Abbreviations: HR - Hazard ratio; CI - Confidence interval